We are live on ! Find out more
BNTX icon

BioNTech

252 hedge funds and large institutions have $4.01B invested in BioNTech in 2023 Q3 according to their latest regulatory filings, with 33 funds opening new positions, 71 increasing their positions, 77 reducing their positions, and 31 closing their positions.

New
Increased
Maintained
Reduced
Closed

6% more first-time investments, than exits

New positions opened: 33 | Existing positions closed: 31

0% more funds holding in top 10

Funds holding in top 10: 44 (0)

0.01% less ownership

Funds ownership: 15.42%15.42% (-0.01%)

0% less funds holding

Funds holding: 253252 (-1)

1% less call options, than puts

Call options by funds: $230M | Put options by funds: $232M

1% less capital invested

Capital invested by funds: $4.05B → $4.01B (-$39.4M)

8% less repeat investments, than reductions

Existing positions increased: 71 | Existing positions reduced: 77

Holders
252
Holders Change
-1
Holders Change %
-0.4%
% of All Funds
4%
Holding in Top 10
4
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.06%
New
33
Increased
71
Reduced
77
Closed
31
Calls
$230M
Puts
$232M
Net Calls
-$1.4M
Net Calls Change
+$90.2M
Name Holding Trade Value Shares
Change
Change in
Stake
GS
76
GTS Securities
New York
$3.29M -$3.11M -28,127 -48%
CCP
77
Crocodile Capital Partners
Germany
$3.21M
CLOS
78
Compagnie Lombard Odier SCmA
Switzerland
$3.21M -$482K -4,360 -13%
Allianz Asset Management
79
Allianz Asset Management
Germany
$3.15M
Parallax Volatility Advisers
80
Parallax Volatility Advisers
California
$3.13M -$1.78M -16,083 -36%
ACM
81
Advisors Capital Management
New Jersey
$3.02M -$119K -1,077 -4%
PFU
82
Parus Finance (UK)
United Kingdom
$2.79M -$382K -3,453 -12%
SC
83
Slow Capital
California
$2.77M -$101K -914 -3%
Squarepoint
84
Squarepoint
New York
$2.74M -$2.35M -21,235 -46%
ERSOT
85
Employees Retirement System of Texas
Texas
$2.57M
BCM
86
Bronte Capital Management
Australia
$2.55M
Amundi
87
Amundi
France
$2.52M +$744K +6,724 +38%
CIS
88
Capital International Sarl
California
$2.42M +$293K +2,645 +13%
Walleye Trading
89
Walleye Trading
New York
$2.38M +$2.42M +21,903 New
CI
90
Capital International
California
$2.27M -$29.5K -267 -1%
GBWM
91
Granite Bay Wealth Management
New Hampshire
$2.25M +$2.25M +20,342 New
GC
92
Guggenheim Capital
Illinois
$2.07M -$439K -3,965 -17%
VA
93
Vident Advisory
Georgia
$2.01M +$2.05M +18,505 New
Capital Fund Management (CFM)
94
Capital Fund Management (CFM)
France
$1.96M +$1.99M +18,035 New
Twin Tree Management
95
Twin Tree Management
Texas
$1.87M -$43.7M -395,296 -96%
LPL Financial
96
LPL Financial
California
$1.49M +$803K +7,257 +113%
Envestnet Asset Management
97
Envestnet Asset Management
Illinois
$1.45M -$282K -2,547 -16%
BNP Paribas Asset Management
98
BNP Paribas Asset Management
France
$1.44M +$154K +1,392 +12%
IFLIT
99
Investmentaktiengesellschaft Fuer Langfristige Investoren TGV
Germany
$1.25M +$55.3K +500 +5%
CII
100
Capital International Inc
California
$1.21M +$165K +1,488 +15%

BNTX Hedge Fund Activity: Q3 2023 in Review

252 of the 6,301 institutional investors tracked by Wall St. Rank reported a position in BioNTech (BNTX) for Q3 2023, worth a combined $4.01B — down 0.97% from $4.05B a quarter earlier.

Buyers outnumbered sellers: 33 funds opened new BNTX positions and 31 closed out — a net gain of 2 holders — while 71 added to existing stakes and 77 trimmed.

The largest buyer was Baillie Gifford & Co, adding an estimated $127M. The largest seller was Artisan Partners, cutting an estimated $143M.

  • 252 institutional investors held BioNTech (BNTX) as of Q3 2023, down from 253 in Q2 2023.
  • Funds reported $4.01B of BioNTech stock for Q3 2023, down 0.97% quarter-over-quarter.
  • 33 funds opened new BioNTech positions in Q3 2023 and 31 closed out, a net change of +2 holders.
  • The largest BioNTech buyer in Q3 2023 was Baillie Gifford & Co, an estimated $127M added.
  • The largest BioNTech seller in Q3 2023 was Artisan Partners, an estimated $143M sold.

Based on aggregated 13F filings for Q3 2023.